| 英文名称 | 中文名称 | CAS | MF |
|
Bupropion morpholinol
|
羟基1-(3-氯苯基)-2-[(1,1-二甲基乙基)氨基]-1-丙酮盐酸盐
|
357399-43-0
|
C13H18ClNO2
|
|
NNC 55-0396 dihydrochloride
|
NNC 55-0396 dihydrochloride
|
357400-13-6
|
C30H39ClFN3O2
|
|
Hydrazinecarboxylic acid, [2-hydroxy-1-(hydroxymethyl)ethylidene]-, 1,1-
|
|
357401-12-8
|
C8H16N2O4
|
|
(1,3-bis(benzyloxy)propan-2-yl)hydrazine hemioxalate
|
(1,3-二(苄氧基)丙烷-2-基)肼半草酸酯
|
357401-15-1
|
C19H24N2O6
|
|
1-Propanone, 1-(3,5-di-β-D-glucopyranosyl-2,4,6-trihydroxyphenyl)-3-(4-hydroxyphenyl)-
|
根皮素-3',5'-二-C-Β-葡萄糖苷
|
357401-40-2
|
C27H34O15
|
|
Acetonitrile, oxo[(2-thienylmethylene)hydrazino]- (9CI)
|
|
357402-37-0
|
C7H5N3OS
|
|
Acetonitrile, oxo[(3-pyridinylmethylene)hydrazino]- (9CI)
|
|
357404-25-2
|
C8H6N4O
|
|
Benzonitrile, 5-fluoro-2-hydroxy-4-methyl- (9CI)
|
5-氟-2-羟基-4-甲基苄腈
|
357404-55-8
|
C8H6FNO
|
|
5-Isoxazolecarboxamide,N-methoxy-N-methyl-(9CI)
|
|
357405-29-9
|
C6H8N2O3
|
|
1-Propanone,3-chloro-1-(5-isoxazolyl)-(9CI)
|
|
357405-31-3
|
C6H6ClNO2
|
|
5-Isoxazolemethanol,-alpha--(2-chloroethyl)-(9CI)
|
|
357405-33-5
|
C6H8ClNO2
|
|
5-Isoxazolemethanol,-alpha--(2-chloroethyl)-,(-alpha-S)-(9CI)
|
|
357405-40-4
|
C6H8ClNO2
|
|
N-methoxy-N-methylthiophene-3-carboxamide
|
|
357405-56-2
|
C7H9NO2S
|
|
4-bromo-2,5-difluorobenzaldehyde
|
4-溴-2,5-二氟苯甲醛
|
357405-75-5
|
C7H3BrF2O
|
|
1-Propanone,3-chloro-1-(3-isoxazolyl)-(9CI)
|
|
357405-87-9
|
C6H6ClNO2
|
|
3-Isoxazolemethanol,-alpha--(2-chloroethyl)-,(-alpha-S)-(9CI)
|
|
357405-89-1
|
C6H8ClNO2
|
|
3-Isoxazolemethanol,-alpha--(2-chloroethyl)-,(-alpha-R)-(9CI)
|
|
357405-94-8
|
C6H8ClNO2
|
|
Acetonitrile, oxo[(4-pyridinylmethylene)hydrazino]- (9CI)
|
|
357405-99-3
|
C8H6N4O
|
|
(R)-(+)-N-Methyl-1-phenylethylamine-d13
|
(R)-(+)-N-甲基-1-苯乙胺-D13
|
357407-86-4
|
C9H13N
|
|
1H-Indene-1,2(3H)-dione,6-ethoxy-,2-oxime(9CI)
|
6-乙氧基-2-肟-1-茚酮
|
357407-89-7
|
C11H11NO3
|
|
1H-Inden-1-ol,2-amino-6-ethoxy-2,3-dihydro-,(1R,2R)-rel-(9CI)
|
|
357407-90-0
|
C11H15NO2
|
|
1H-Inden-1-ol,2-amino-6-ethoxy-2,3-dihydro-,(1S,2S)-(9CI)
|
|
357407-91-1
|
C11H15NO2
|
|
2-Amino-6-methoxy-indan-1-ol hydrochloride
|
|
357407-97-7
|
C10H13NO2
|
|
1H-Inden-2-amine,2,3-dihydro-5-methoxy-,(2S)-(9CI)
|
|
357407-99-9
|
C10H13NO
|
|
N-(1-naphthyl)-2-[2-(1-naphthylmethylene)hydrazino]-2-oxoacetamide
|
|
357410-18-5
|
C23H17N3O2
|
|
(S)-Methyl 4-(Boc-amino)-2-hydroxybutanoate
|
(S)-Methyl 4-(Boc-amino)-2-hydroxybutanoate
|
357416-82-1
|
C10H19NO5
|
|
3-Cyclohexene-1-carboxylicacid,1-methyl-,methylester,(1R)-(9CI)
|
|
357418-50-9
|
C9H14O2
|
|
3-Cyclohexene-1-carboxylicacid,1-methyl-,methylester,(1S)-(9CI)
|
|
357418-53-2
|
C9H14O2
|
|
2-[(2,5-Dimethyl-furan-3-carbonyl)-amino]-benzoic acid
|
2-(2,5-二甲基呋喃-3-甲酰胺基)苯甲酸
|
357420-38-3
|
C14H13NO4
|
|
5-Oxazolidinemethanol,2,3-dimethyl-2-(1-methylethyl)-(9CI)
|
|
357420-44-1
|
C9H19NO2
|
|
Benzoic acid, 4-methoxy-, [[5-(dimethylamino)-2-furanyl]methylene]hydrazide (9CI)
|
|
357420-95-2
|
C15H17N3O3
|
|
Phenol, 4-methoxy-2-[(methylimino)methyl]- (9CI)
|
|
357423-77-9
|
C9H11NO2
|
|
Varenicline Impurity 13
|
伐尼克兰杂质13
|
357424-07-8
|
C13H13N3O2
|
|
5,9-Methanoimidazo[4,5-h][3]benzazepine,1,5,6,7,8,9-hexahydro-(9CI)
|
伐伦克林杂质
|
357424-12-5
|
C12H13N3
|
|
Hydroxy Varenicline
|
伐伦克林杂质
|
357424-21-6
|
C13H13N3O
|
|
Hydroxy Varenicline N-Trifluoroacetate
|
伐伦克林杂质
|
357426-10-9
|
C15H12F3N3O2
|
|
methyl 3-(aminomethyl)-2,3-dihydro-1H-indene-1-carboxylate
|
3-(氨基甲基)-2,3-二氢-1H-茚-1-羧酸甲酯
|
357426-12-1
|
C12H15NO2
|
|
1,3,4,5-Tetrahydro-1,5-methano-2H-3-benzazepin-2-one
|
1,3,4,5-四氢-1,5-亚甲基-2H-3-苯骈吖庚因-2-酮
|
357426-13-2
|
C11H11NO
|
|
2-Oxazolidinone,4-(1-methylethyl)-3-(1,2-propadienyl)-,(4R)-(9CI)
|
|
357426-83-6
|
C9H13NO2
|
|
1,2-Benzenedimethanol,-alpha-,-alpha--diethyl-,(-alpha-S,-alpha-S)-(9CI)
|
|
357427-66-8
|
C12H18O2
|
|
1,2-Benzenedimethanol,-alpha-,-alpha--diethyl-,(-alpha-R,-alpha-R)-(9CI)
|
|
357427-68-0
|
C12H18O2
|
|
1,2-Benzenedimethanol,-alpha--ethyl--alpha--methyl-,(-alpha-S,-alpha-S)-(9CI)
|
|
357427-84-0
|
C11H16O2
|
|
1H,5H-Pyrrolo[2,1-c][1,4]oxazepin-5-one,hexahydro-3-methoxy-,(3S,9aS)-(9CI)
|
|
357428-36-5
|
C9H15NO3
|
|
1H,5H-Pyrrolo[2,1-c][1,4]oxazepin-5-one,hexahydro-3-methoxy-,(3R,9aS)-(9CI)
|
|
357428-48-9
|
C9H15NO3
|
|
3,6-Dibromo-9-(p-tolyl)-9H-carbazole
|
3,6-二溴-9-(4-甲基苯基)-9H-咔唑
|
357437-74-2
|
C19H13Br2N
|
|
tert-butyl 4-amino-4-phenylbutylcarbamate
|
叔-丁基 N-(4-氨基-4-苯基丁基)氨基甲酯
|
357443-58-4
|
C15H24N2O2
|
|
4,7-dihydro-1-Methyl-4,7-Ethano-2H-isoindole
|
4,7-二氢-1-甲基-4,7-桥亚乙基-2H-异吲哚
|
357608-23-2
|
C11H13N
|
|
4-(Diethylamino)-3-nitropyridine
|
|
357608-93-6
|
C9H13N3O2
|
|
1-[2-(Diethylamino)-5-nitro-4-pyridinyl]-ethanone
|
|
357608-96-9
|
C11H15N3O3
|
|
N-Boc-beta-alanine-beta-methyl-N-carboxyanhydride
|
N-BOC-BETA-ALANINE-BETA-METHYL-N-CARBOXYANHYDRIDE
|
357610-31-2
|
C10H15NO5
|
|
N-Boc-beta-alanine-alpha-methyl-N-carboxyanhydride
|
N-BOC-BETA-ALANINE-ALPHA-METHYL-N-CARBOXYANHYDRIDE
|
357610-32-3
|
C10H15NO5
|
|
1H-Phenalene-5,6-diol, 2,3,7,9a-tetrahydro- (9CI)
|
|
357610-78-7
|
C13H14O2
|
|
2-tert-butyl-4-fluorophenol
|
2-TERT-BUTYL-4-FLUORO-PHENOL
|
357611-22-4
|
C10H13FO
|
|
3,5-Dimethyl-4-propoxyphenylboronic acid
|
3,5-二甲基-4-丙氧基苯硼酸
|
357611-51-9
|
C11H17BO3
|
|
Benzenemethanethiol, 2-fluoro-3-methyl- (9CI)
|
2-Fluoro-3-methylbenzenemethanethiol
|
357613-02-6
|
C8H9FS
|
|
Benzenemethanethiol, 2-fluoro-5-methyl- (9CI)
|
2-Fluoro-5-methylbenzenemethanethiol
|
357613-07-1
|
C8H9FS
|
|
galiximab
|
加利昔单抗
|
357613-77-5
|
|
|
Lumiliximab
|
LUMILIXIMAB ( 鲁昔单抗 )
|
357613-86-6
|
|
|
N-(3-Hydroxypropyl)-1H-indole-2-carboxamide
|
N-(3-HYDROXYPROPYL)-1H-INDOLE-2-CARBOXAMIDE
|
357616-16-1
|
C12H14N2O2
|
|
2-(4-pyridinyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one
|
|
357618-22-5
|
C15H13N3OS
|
|
1-Naphthalenol,2-fluoro-1,2-dihydro-,(1R,2R)-(9CI)
|
|
357625-18-4
|
C10H9FO
|
|
1-Indolizinemethanol(9CI)
|
吲哚嗪-1-乙醇
|
357627-48-6
|
C9H9NO
|
|
(1R,2S)-erythro-Dihydro Bupropion Hydrochloride
|
（1R，2S）-赤二氢安非他酮盐酸盐
|
357628-62-7
|
C13H21Cl2NO
|
|
threo-Hydroxy Bupropion HCl
|
盐酸苏式安非他酮
|
357637-18-4
|
C13H21Cl2NO
|
|
3-Oxo-3,4-dihydro-quinoxaline-6-carboxylic acid methyl ester
|
3,4-二氢-3-氧代-6-喹喔啉羧酸甲酯
|
357637-38-8
|
C10H8N2O3
|
|
Propanamide, N-(2,2-dichloroethenyl)-2-methyl-
|
|
357639-08-8
|
C6H9Cl2NO
|
|
6-Hydroxy-4-(4-hydroxy-3-methoxyphenyl)-3-hydroxymethyl-7-methoxy-3,4-dihydro-2-naphthaldehyde
|
6-羟基-4-(4-羟基-3-甲氧基苯基)-3-羟基甲基-7-甲氧基-3,4-二氢-2-萘甲醛
|
357645-16-0
|
C20H20O6
|
|
2,7-Dibromo-9,9-bis(4-methylphenyl)-9H-fluorene
|
2,7-二溴-9,9-双(4-甲基苯基)-9H-芴
|
357645-37-5
|
C27H20Br2
|
|
9H-Fluorene-2,7-diamine, N2,N7-di-1-naphthalenyl-N2,N7,9,9-tetraphenyl-
|
N2,N7-DI-1-萘基-N2,N7,9,9-四苯基-9H-芴-2,7-二胺
|
357645-40-0
|
C57H40N2
|
|
4-(4-Hydroxy-3-methoxy-benzylidene)-3-phenyl-4H-isoxazol-5-one
|
|
357647-20-2
|
C17H13NO4
|
|
2-Pyrimidinepentanal (9CI)
|
|
357647-60-0
|
C9H12N2O
|
|
4-Pyrimidinebutanal (9CI)
|
|
357647-66-6
|
C8H10N2O
|
|
2-Pyrimidinepropanal,5-fluoro-(9CI)
|
|
357647-69-9
|
C7H7FN2O
|
|
1-(4-Bromophenyl)-4-(methylsulfonyl)piperazine
|
1-(4-BROMOPHENYL)-4-(METHYLSULFONYL)PIPERAZINE
|
357647-98-4
|
C11H15BrN2O2S
|
|
Histone Acetyltransferase Inhibitor IV, CPTH2
|
CPTH2
|
357649-93-5
|
C14H14ClN3S
|
|
n-Butyl 3-chloropyridine-2-carboxylate
|
|
357653-68-0
|
C10H12ClNO2
|
|
2-Pyrimidinepropanal, 5-ethyl- (9CI)
|
|
357654-97-8
|
C9H12N2O
|
|
3-Cyclobutene-1,2-dione, 3-(4-ethyl-3,5-dimethyl-1H-pyrrol-2-yl)-4-hydroxy- (9CI)
|
|
357657-16-0
|
C12H13NO3
|
|
4-[(5-nitropyridin-2-yl)oxy]benzaldehyde
|
|
357663-53-7
|
C12H8N2O4
|
|
ethyl 1-(2-cyanophenyl)piperidine-4-carboxylate
|
ethyl 1-(2-cyanophenyl)piperidine-4-carboxylate
|
357670-16-7
|
C15H18N2O2
|
|
2(3H)-Benzothiazolethione,5-butyl-(9CI)
|
|
357675-00-4
|
C11H13NS2
|
|
3-(Methylsulfonyl)propyl Methanesulfonate
|
3-(甲基磺酰基)丙基甲磺酸酯
|
357913-53-2
|
C5H12O5S2
|
|
1-Heptyl-3-Methyl-Imidazolium Hexafluorophosphate
|
1-庚基-3-甲基咪唑三氟甲磺酸盐
|
357915-04-9
|
C11H21F6N2P
|
|
Piperazine, 1-methyl-4-(tetrahydro-2-furanyl)- (9CI)
|
|
357916-06-4
|
C9H18N2O
|
|
Piperazine, 1-methyl-4-(tetrahydro-2H-pyran-2-yl)- (9CI)
|
|
357916-08-6
|
C10H20N2O
|
|
Androst-5-en-17-one, 3-(acetyloxy)-7-methoxy-, (3beta)- (9CI)
|
|
357923-24-1
|
C22H32O4
|
|
2-Bromo-4-fluoropyridine
|
2-溴-4-氟吡啶
|
357927-50-5
|
C5H3BrFN
|
|
1-(4-chlorophenyl)-5-[3-(trifluoromethyl)phenyl]-3a,6a-dihydrospiro(1H-furo[3,4-c]pyrrole-3,2'-[1'H]-indene)-1',3',4,6(2'H,3H,5H)-tetrone
|
|
357932-91-3
|
C27H15ClF3NO5
|
|
1-Ethylpiperidin-4-aMine, HCl
|
N-乙基-4-氨基哌啶二盐酸盐
|
357935-97-8
|
C7H17ClN2
|
|
Pyrrolidine, 4-methoxy-2-(methoxymethyl)-1-(2-propenyl)-, (2R,4R)-rel- (9CI)
|
|
357945-64-3
|
C10H19NO2
|
|
Stresscopin (3-40) (human) trifluoroacetate salt
|
UROCORTIN III (HUMAN)
|
357952-09-1
|
C185H307N53O50S2
|
|
Ftlsldvptnimnilfnidkaknlrakaaanaqlmaqi-NH2
|
UROCORTIN II (MOUSE)
|
357952-10-4
|
C186H312N52O52S2
|
|
Acetic acid, [2-acetyl-1-(1-methylethyl)hydrazino]-, methyl ester (9CI)
|
|
357953-63-0
|
C8H16N2O3
|
|
Pyrimidine, 4-(3,5-dimethyl-1H-pyrazol-1-yl)-6-methoxy-2-phenyl-
|
|
357960-86-2
|
C16H16N4O
|
|
N-[(4S)-4-Amino-5-[(2-aminoethyl]amino]p
|
N-[(4S)-4-AMINO-5-[(2-AMINOETHYL]AMINO]P
|
357965-99-2
|
C8H21N7O2.3C2HF3O2
|
|
cis-2-(3-Chlorobenzoyl)cyclohexane-1-carboxylic acid
|
(1R,2S)-2-(3-氯苯甲酰基)环己烷-1-羧酸
|
357980-62-2
|
C14H15ClO3
|
|
cis-2-(3-Methoxybenzoyl)cyclohexane-1-carboxylic acid
|
|
357980-63-3
|
C15H18O4
|
|
(2S,3S,4S,5R,6R)-6-azido-3,4,5-trihydroxyoxane-2-carboxylic acid
|
1-三氮-BETA-D葡萄糖酸
|
357981-14-7
|
C6H9N3O6
|
|
1,4-Dioxaspiro[4.5]dec-7-ene, 9-methyl-
|
|
357981-41-0
|
C9H14O2
|
|
2-Propenamide, 2-cyano-3-[5-(dimethylamino)-2-furanyl]-N-(3-methylphenyl)-
|
|
357984-70-4
|
C17H17N3O2
|